Ceeli Thairianathan: Bridging Biotechnology and Clinical Application
Ceeli Thairianathan, Northeastern Graduate Student, shared a post on LinkedIn:
“Bridging Biotechnology and Clinical Application: Key Insights from Biocytogen
As a biotechnology graduate student, I recently attended a webinar by Biocytogen on the critical role of humanized models in navigating the complexities of cardio-metabolic drug discovery.
Here is a concise technical summary of the platform’s capabilities:
1. Next-Gen Anticoagulation:
Biocytogen is utilizing B-hFXI and B-hFXII plus mice to target the intrinsic coagulation pathway.
This strategy aims to uncouple dangerous thrombosis from essential physiological hemostasis.
2. Precision Cardiomyopathy Models:
The B-Mybpc3 KO model demonstrates high phenotypic fidelity to human disease, exhibiting cardiac enlargement and ventricular wall thickening.
Masson-staining in 17-week-old models provides clear evidence of endocardial collagen fiber proliferation.
3. Systemic Metabolic Solutions:
Advanced multi-target models, such as the B-hLPA/hAPOB/hPCSK9 plus mice, are engineered to evaluate therapies for atherosclerosis and hyperlipidemia.
The broader portfolio addresses NAFLD/MASH, Hyperuricemia, and Diabetic Nephropathy.
4. Integrated Assay Platform:
Beyond the models, Biocytogen provides a robust analytical framework including MSD, FACS, and Luminex to support comprehensive PK/PD/Tox/MoA studies.
These integrated preclinical solutions are essential for accelerating the transition from laboratory research to successful IND filing.
I am grateful for the expert insights shared during this session, which underscored the importance of humanized precision in modern drug discovery.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 05:53Manuel Gutiérrez de Ravé: My Personal Takeaways from 39th International ISBT Annual Congress
-
Jun 27, 2026, 05:4710-Minute Paper-Strip Test Detects Factor VIII Inhibitors in Resource-Limited Settings – JTH
-
Jun 27, 2026, 05:23New episode – From Groundbreaking Therapies to the Ongoing Fight for Diagnosis – Global Hemophilia Report
-
Jun 27, 2026, 05:08Bethany Brown: Over 400 Ground EMS Agencies Now Carry Lifesaving Blood
-
Jun 27, 2026, 04:56Reza Shojaei: The Plasma Risk Governments Are Ignoring
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI